All News

Radical prostatectomy is associated with a substantial long-term reduction in mortality in men with localized cancer, especially in younger patients, according to newly published data from one of the few randomized trials to directly address the surgery-versus-surveillance issue.

Prostate cancer patients who undergo robot-assisted radical prostatectomy have fewer positive surgical margins and less need for additional cancer treatments such as hormone or radiation therapy than patients undergoing open surgery, an observational study from UCLA’s Jonsson Comprehensive Cancer Center has found.

Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University, Bronx, NY, have named Mark Schoenberg, MD, professor and university chair of the department of urology. He will assume his new position in April 2014.

Most prostate cancer experts aren’t ready to call the incorporation of MRI fusion into prostate biopsies the gold standard in prostate cancer imaging and diagnosis. But they envision a day when it will be.

Drugs and devices in the pipeline from VIVUS, Auxilium Pharmaceuticals, OncoGenex Pharmaceuticals, Veloxis Pharmaceuticals, OPKO Health, and Oxthera AB.

High-dose supplementation with both selenium and vitamin E increases the risk of high-grade prostate cancer, according to a recent multicenter study. This risk depends upon a man’s selenium status before taking the supplements.

The type of primary treatment received for prostate cancer-surgery or radiation therapy-is the strongest predictor of lesser-known complications such as the need for additional surgical procedures and development of secondary cancers, according to the authors of a recently published study from the University of Toronto.

The advantages that robotic technologies bring to prostate procedures, partial nephrectomies, and other surgeries that can involve complex reconstruction are not readily apparent in simple extirpative surgeries such as radical nephrectomy. This raises two questions: Are robots being used in radical nephrectomies and if so, why?

The second-generation androgen receptor antagonist enzalutamide (XTANDI) significantly improved survival and delayed the time to chemotherapy in men with previously untreated metastatic castrate-resistant prostate cancer, according to a recent study.

Promotion of strategies for the repeal of the sustainable growth rate formula and preservation of access to appropriate PSA screening are among the AUA’s top legislative priorities for 2014, the association announced.

In an age where physician fees are primarily determined by the Centers for Medicare & Medicaid Services, insurers who negotiate a percentage of Medicare, or value-based reimbursement programs, it is reasonable to examine the purpose and method of creating and maintaining a master fee schedule, or “charge master.”

Medications that have to be injected or instilled are considered Medicare Part B drugs, and for many offices, these are a money-losing proposition. However, you have a few options that will allow you to provide the needed medications to your patients without loss of revenue.

As thousands of baby boomers age into Medicare every day and millions of newly insured Americans seek health care, analysts point to expanded utilization of telehealth services as one way to alleviate physician shortages and ensure access to care.

In this article, I outline my patient discussion concerning prostate cancer screening, which includes defining what the PSA test is, why to screen or not to screen, the screening controversy, current guidelines, and decision aids.

Prostate cancer patients treated with androgen deprivation therapy experienced changes in mental and emotional well-being during treatment, although there was no meaningful decline in emotional quality of life 2 years after treatment, a recent study found.

It certainly makes sense to try to avoid kiddie tax exposure through effective tax planning strategies. The key is to keep your child’s unearned income below or near the $2,000 threshold.